Invesco Ltd. Biolife Solutions Inc Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Invesco Ltd. holds 3,599,444 shares of BLFS stock, worth $86.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,599,444

Previous 3,580,778 0.52%

Holding current value

$86.6 Million

Previous $77.1 Million 19.05%

% of portfolio

0.02%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$20.64 - $26.74 $385,266 - $499,128	18,666 Added 0.52%	3,599,444 $91.8 Million
Q2 2025 Aug 13, 2025	BUY	$20.64 - $25.27 $613,503 - $751,125	29,724 Added 0.84%	3,580,778 $77.1 Million
Q1 2025 May 12, 2025	BUY	$22.84 - $28.49 $7.12 Million - $8.88 Million	311,585 Added 9.62%	3,551,054 $81.1 Million
Q4 2024 Feb 13, 2025	BUY	$20.47 - $27.47 $740,522 - $993,754	36,176 Added 1.13%	3,239,469 $84.1 Million
Q3 2024 Nov 12, 2024	SELL	$19.19 - $26.52 $2.24 Million - $3.1 Million	-116,838 Reduced 3.52%	3,203,293 $80.2 Million
Q2 2024 Aug 13, 2024	BUY	$15.14 - $22.99 $31 Million - $47 Million	2,044,714 Added 160.32%	3,320,131 $71.2 Million
Q1 2024 May 14, 2024	BUY	$15.35 - $18.82 $1.41 Million - $1.73 Million	91,858 Added 7.76%	1,275,417 $23.7 Million
Q4 2023 Feb 12, 2024	BUY	$8.99 - $16.86 $1.18 Million - $2.22 Million	131,494 Added 12.5%	1,183,559 $19.2 Million
Q3 2023 Nov 13, 2023	BUY	$10.81 - $22.96 $696,974 - $1.48 Million	64,475 Added 6.53%	1,052,065 $14.5 Million
Q2 2023 Aug 11, 2023	BUY	$17.19 - $24.34 $3.09 Million - $4.38 Million	179,950 Added 22.28%	987,590 $21.8 Million
Q1 2023 May 12, 2023	BUY	$17.67 - $26.07 $149,912 - $221,177	8,484 Added 1.06%	807,640 $17.6 Million
Q4 2022 Feb 13, 2023	BUY	$16.95 - $25.07 $449,988 - $665,558	26,548 Added 3.44%	799,156 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $244,297 - $445,542	16,687 Added 2.21%	772,608 $17.6 Million
Q2 2022 Aug 15, 2022	SELL	$10.54 - $24.2 $48,146 - $110,545	-4,568 Reduced 0.6%	755,921 $10.4 Million
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $192,430 - $344,820	-9,247 Reduced 1.2%	760,489 $17.3 Million
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $5.38 Million - $9.55 Million	163,176 Added 26.9%	769,736 $28.7 Million
Q3 2021 Nov 15, 2021	BUY	$42.03 - $60.5 $4.71 Million - $6.78 Million	112,099 Added 22.67%	606,560 $25.7 Million
Q2 2021 Aug 17, 2021	BUY	$29.51 - $44.62 $2.21 Million - $3.34 Million	74,816 Added 17.83%	494,461 $22 Million
Q1 2021 May 17, 2021	BUY	$32.95 - $44.24 $9.19 Million - $12.3 Million	278,914 Added 198.19%	419,645 $15.1 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $45.75 $310,200 - $516,060	-11,280 Reduced 7.42%	140,731 $5.61 Million
Q3 2020 Nov 16, 2020	BUY	$16.04 - $28.94 $2.44 Million - $4.4 Million	152,011 New	152,011 $4.4 Million
Q4 2019 Feb 14, 2020	SELL	$14.59 - $18.9 $150,831 - $195,388	-10,338 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $1.11 Million - $1.49 Million	-70,981 Reduced 87.29%	10,338 $172,000
Q2 2019 Aug 14, 2019	BUY	$15.2 - $19.42 $55,768 - $71,251	3,669 Added 4.73%	81,319 $1.38 Million
Q1 2019 May 15, 2019	BUY	$10.9 - $21.26 $564,412 - $1.1 Million	51,781 Added 200.17%	77,650 $1.39 Million
Q4 2018 Feb 14, 2019	BUY	$9.5 - $17.17 $245,755 - $444,170	25,869 New	25,869 $311,000

Others Institutions Holding BLFS

# of Institutions

206

Shares Held

47.7M

Call Options Held

12.6K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.03B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account